UK Government Raises Health‑AI Framework Ceiling to £750 million After Supplier Consultation

Regulatory action → What it requires → Compliance timeline

Regulatory action – The Department for Health and Social Care, acting through NHS Shared Business Services (NHS SBS), has amended the maximum value of the NHS AI and Robotics Framework Agreement. The ceiling has been lifted from £150 million (the figure used in the January 2025 market engagement) to £750 million (excluding tax). The amendment was endorsed by NHS England, the Cabinet Office and the Department for Science, Innovation and Technology.

What it requires – Suppliers wishing to join the framework must now be prepared to compete for contracts that could collectively reach up to £750 million. The framework is divided into eight lots, each covering a distinct set of AI‑driven capabilities:

1. Radiology and Diagnostic Imaging – AI‑powered image analysis tools, diagnostic platforms and integrated software that support clinical decision‑making.
2. Virtual and Robotic Health – Solutions that augment clinical capabilities, improve patient outcomes and increase operational efficiency through robotics or virtual care.
3. Operational Efficiency Platforms – Systems for data capture, analytics and workflow automation across NHS and other public‑sector environments.
4. Clinical Decision Support – Algorithms that assist clinicians with diagnosis, treatment planning and risk stratification.
5. Population Health Management – Predictive models that identify trends, allocate resources and support preventive care.
6. Patient‑Facing Applications – Chat‑bots, triage tools and mobile health apps that engage patients directly.
7. Supply‑Chain Optimisation – AI tools that forecast demand, manage inventories and reduce waste.
8. Security and Governance – Solutions that ensure data protection, model transparency and compliance with the UK GDPR and the NHS Data Security and Protection Toolkit.

Each lot will be awarded on the basis of pre‑agreed pricing, with NHS SBS applying a levy to all transactions concluded under the framework. Suppliers must demonstrate:

• Proven clinical efficacy (e.g., peer‑reviewed studies, real‑world performance data).
• Alignment with NHS digital standards, including the NHS Interoperability Toolkit.
• Robust governance, covering model explainability, bias mitigation and post‑deployment monitoring.
• Full compliance with the UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018.

Compliance timeline – The revised framework will be launched on 1 September 2026. Suppliers have until 31 October 2026 to submit their expressions of interest (EOI). Following the EOI stage, a shortlist will be invited to a detailed technical and commercial submission by 30 December 2026. Contract awards are expected by March 2027, with the first framework‑based purchases scheduled for June 2027.

Why the increase matters

The £600 million uplift reflects feedback from both potential buyers and vendors that the original £150 million ceiling would constrain the scale of AI adoption across the NHS. By raising the cap, the government aims to:

• Enable larger, multi‑year AI deployments that can achieve economies of scale.
• Provide a more attractive market for international and domestic AI firms, encouraging competition and innovation.
• Align the framework’s financial scope with the broader public‑sector AI ambition, which the Treasury estimates could generate £45 billion in net savings if realised.

Practical steps for suppliers

1. Review the procurement notice on the Contracts Finder portal and download the full tender documentation.
2. Map your solution against the eight lots, focusing on clinical evidence, data security certifications and cost‑benefit analysis.
3. Prepare a compliance matrix that references UK GDPR, the NHS Data Security and Protection Toolkit and any relevant medical device regulations (e.g., UK MDR 2002).
4. Submit the EOI before the 31 October 2026 deadline, ensuring all required artefacts (clinical studies, security assessments, pricing models) are attached.
5. Plan for post‑award monitoring by establishing a governance framework that includes regular performance reporting, model drift detection and a clear escalation path for adverse events.

Outlook

The expanded framework represents a significant policy shift: the UK government is now committing substantially more public funds to AI‑enabled health services. While the financial commitment is large, success will depend on rigorous supplier compliance, transparent performance metrics and ongoing oversight by NHS England and the relevant regulatory bodies. Stakeholders are advised to treat the upcoming tender as a long‑term partnership rather than a one‑off transaction, given the multi‑year spend horizon embedded in the £750 million ceiling.